SNX1 and Parkinson disease: Thus, we investigated the physical interaction between DNAJC13 and SNX1 and its effect on the subcellular localization of M6PR using cells treated with the mitochondrial complex I inhibitor, rotenone, a dopaminergic neurotoxin widely used to generate a pharmacological PD model [38].